Zografi to speak in China

George Zografi, dean and professor emeritus, has been invited to speak at the 1st Asian Arden Conference in Beijing, China in October 2008. The conference is co-sponsored by the American Association of Pharmaceutical Scientists and …

Hak Auth accepts naval position

Hak Auth, PhD ’08, has accepted a position as a scientist-officer in the U.S. Navy Medical Services Corps. Auth will be reporting to Jacksonville, Florida later this month to begin his naval career. During his …

FDA explores oversight of nanotechnology

The nanotechnology research of Darin Furgeson, assistant professor in the Pharmaceutical Sciences Division, is referenced in the July 25 edition of Science Progress. The Food and Drug Administration’s Nanotechnology Task Force has been created to …

Start-up company begins testing Alzheimer’s drug

Mithridion, a drug development company, co-founded by Jeff Johnson, professor in the Pharmaceutical Sciences Division, began a Phase 1 clinical trial of MCD-386, a small-molecule compound designed to treat Alzheimer’s patients. As highlighted in the …

Professor Kwon named to editorial board

Glen Kwon, professor in the Pharmaceutical Sciences Division, was named a member of the editorial board of the Biopharmaceutics & Drug Disposition Journal. This journal focuses on biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those …

New business aimed at drug delivery

A start-up drug delivery company using technologies developed by three UW-Madison professors–pharmacy professors Sandro Mecozzi and Glen Kwon, and anesthesiology Professor Robert Pearce–as well as chemistry graduate student Jonathan Fast was featured in the May …

Bar Ilan named Young Investigator

Ofek Bar-Ilan, pharmaceutical sciences PhD graduate student in the laboratory of Darin Furgeson, assistant professor in the Pharmaceutical Sciences Division and Biomedical Engineering, received the Young Investigator Award from the Midwest Regional Chapter of the …

Editorial appointments recognize research

Mel de Villiers, associate professor in the Pharmaceutical Sciences Division, has been selected to serve on the Editorial Board of Current Drug Discovery Technologies. He was also recently appointed as an Associate Editor for the …